Tenaya Therapeutics Inc (NASDAQ: TNYA) on Monday, soared 8.08% from the previous trading day, before settling in for the closing price of $0.7. Within the past 52 weeks, TNYA’s price has moved between $0.36 and $2.35.
A company in the Healthcare sector has dropped its sales by -15.57% annually for the last half of the decade. The company achieved an average annual earnings per share of 52.96%. With a float of $199.53 million, this company’s outstanding shares have now reached $216.51 million.
Tenaya Therapeutics Inc (TNYA) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tenaya Therapeutics Inc is 7.84%, while institutional ownership is 14.48%. The most recent insider transaction that took place on Nov 17 ’25, was worth 1,818. In this transaction SVP, Finance of this company sold 1,367 shares at a rate of $1.33, taking the stock ownership to the 93,971 shares. Before that another transaction happened on Nov 17 ’25, when Company’s Chief Medical Officer sold 2,877 for $1.33, making the entire transaction worth $3,826. This insider now owns 169,926 shares in total.
Tenaya Therapeutics Inc (TNYA) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.28 earnings per share (EPS) for the period topping the consensus outlook (set at -0.31) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 52.96% per share during the next fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
Tenaya Therapeutics Inc (TNYA) is currently performing well based on its current performance indicators. A quick ratio of 4.64 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.49 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Let’s dig in a bit further. During the last 5-days, its volume was 7.4 million. That was better than the volume of 3.54 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 6.07%.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 6.72%, which indicates a significant decrease from 12.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0961 in the past 14 days, which was lower than the 0.1221 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3673, while its 200-day Moving Average is $0.9452. However, in the short run, Tenaya Therapeutics Inc’s stock first resistance to watch stands at $0.7890. Second resistance stands at $0.8210. The third major resistance level sits at $0.8754. If the price goes on to break the first support level at $0.7026, it is likely to go to the next support level at $0.6482. The third support level lies at $0.6162 if the price breaches the second support level.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
Market capitalization of the company is 163.92 million based on 166,506K outstanding shares. Right now, sales total 0 K and income totals -111,130 K. The company made 0 K in profit during its latest quarter, and -20,280 K in sales during its previous quarter.
